1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow JNJ-55308942 0.5 mg: new trials by email Literature Review of JNJ-55308942 0.5 mg trials Research Report on JNJ-55308942 0.5 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female Participants JNJ-55308942 0.5 mg, JNJ-55308942 1.5 mg, JNJ-55308942 4 mg - Healthy | Phase 1 | Completed | Janssen-Cilag International NV | 98 | 2017-05-03 | 2025-04-27 |
Janssen-Cilag International NV (1)
Belgium (1)
2017 (1)